Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Roundup: FTC, FDA Enforcement, Mannatech CEO, Quell Distribution

This article was originally published in The Tan Sheet

Executive Summary

FTC commissioner questions enforcement; Mannatech adds CEO to Bala’s title; Quell wearable pain relief heads for stores; ED drug in ‘Herb Viagra’; and more news in brief.

You may also be interested in...



US Health And Wellness People News: CHPA Award, Herbalife, Mannatech C-Suite Changes, More

DeSimone returns as Herbalife CFO; Mannatech CEO Bala leaving on 1 April with Fredrick moving to post; CHPA lifetime achievement award for former Perrigo exec Needham; comedian hacks healthy nutrition for Quest; “John Wick” inspires Jacked; NBA player assists Earth Splendor; HRG owner group expands with HR director.

Injunction Ends Spiked Supplement Marketers' Attempt To Deceive FDA

Other than making apparently false statements to FDA about no longer selling spiked supplements, operators of R Thomas Marketing, identified online as a social media consultancy, and S Hackett Marketing, which d/b/a "Just Enhance" and apparently sells a variety of consumer goods, made no contact with FDA or with DoJ, according to court order entered as a permanent injunction.

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel